Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges
European Journal of Drug Metabolism and Pharmacokinetics · 2024
DOI: 10.1007/s13318-024-00882-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Drug Metabolism and Pharmacokinetics, 2024. Verfasst von Marta Colaneri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy. marta.colaneri@gmail.com. Hauptthemen laut MEDLINE: Drug Users, Methicillin-Resistant Staphylococcus aureus, Substance Abuse, Intravenous. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
Intravenous drug users (IVDUs) face heightened susceptibility to life-threatening gram-positive bacterial infections, particularly methicillin-resistant Staphylococcus aureus (MRSA). While the standard antibiotic dosing strategies for special patients, such as obese or critically ill individuals, are known to be inadequate, raising concerns about treatment efficacy, a similar sort of understanding has not been assessed for IVDUs yet. With this in mind, this review examines the pharmacokinetic/pharmacodynamic characteristics of antibiotics commonly used against gram-positive bacteria in IVDUs. Focusing on daptomycin, vancomycin, teicoplanin, aminoglycosides, and the novel lipoglycopeptide dalbavancin, the study reveals significant pharmacokinetic variations in IVDUs, suggesting the need for personalized dosing. Concomitant opioid substitution therapy and other factors, such as malnutrition, contribute to altered pharmacokinetics/pharmacodynamics, emphasizing the importance of targeted therapeutic drug monitoring. Overall, our study calls for increased awareness among clinicians regarding the unique pharmacokinetic/pharmacodynamic challenges in IVDUs and advocates for tailored antibiotic dosing strategies to enhance treatment outcomes in this marginalized population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy. marta.colaneri@gmail.com.
- Infectious Diseases Unit, L. Sacco Hospital, Milan, Italy. marta.colaneri@gmail.com.
- Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
- Infectious Diseases I Unit, IRCCS San Matteo, Pavia, Italy.
- Centre for Multidisciplinary Research in Health Science (MACH), University of Milano, Milan, Italy.
- Department of Medical, Surgical, Diagnostic and Paediatric Science, University of Pavia, Pavia, Italy.
Zitieren
APA
Colaneri, M., Genovese, C., Valsecchi, P., Calia, M., Cattaneo, D., Gori, A., Bruno, R., & Seminari, E. (2024). Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges. European Journal of Drug Metabolism and Pharmacokinetics. https://doi.org/10.1007/s13318-024-00882-8
Vancouver
Colaneri M, Genovese C, Valsecchi P, Calia M, Cattaneo D, Gori A, et al. Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges. European Journal of Drug Metabolism and Pharmacokinetics. 2024. doi:10.1007/s13318-024-00882-8
BibTeX
@article{Colaneri2024,
author = {Colaneri, Marta and Genovese, Camilla and Valsecchi, Pietro and Calia, Matteo and Cattaneo, Dario and Gori, Andrea and Bruno, Raffaele and Seminari, Elena},
title = {Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges},
journal = {European Journal of Drug Metabolism and Pharmacokinetics},
year = {2024},
doi = {10.1007/s13318-024-00882-8}
}
EUVIMED